CPC A61K 31/573 (2013.01) [A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 9/107 (2013.01); A61K 9/12 (2013.01); A61K 31/192 (2013.01); A61K 31/4436 (2013.01); A61K 45/06 (2013.01); A61K 47/14 (2013.01); A61K 47/26 (2013.01); A61K 47/44 (2013.01)] | 2 Claims |
1. A pharmaceutical composition consisting essentially of:
tazarotene, 0.045% w/w,
diethyl sebacate, 2.97% w/w,
light mineral oil, 8.03% w/w,
sorbitan monooleate, 0.1% w/w,
sorbitol solution (70%), 10.7% w/w,
methyl paraben, 0.17% w/w,
propyl paraben, 0.03% w/w,
edetate disodium dihydrate, 0.05% w/w,
carbomer copolymer type B, 0.4% w/w,
carbomer homopolymer type A, 0.6% w/w,
sodium hydroxide, q.s. to pH of 5.5±0.5, and
purified water, q.s. to 100% w/w;
wherein the composition is a lotion.
|